EVERSANA
Founded Year
2018Stage
Other Investors | AliveAbout EVERSANA
EVERSANA provides services to the life sciences industry. The company offers integrated solutions that are based on the patient experience and cover various stages of the product life cycle. EVERSANA serves the life sciences sector, including pharmaceutical companies and healthcare organizations. It was founded in 2018 and is based in Milwaukee, Wisconsin.
Loading...
Loading...
Expert Collections containing EVERSANA
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
EVERSANA is included in 1 Expert Collection, including Conference Exhibitors.
Conference Exhibitors
5,302 items
Latest EVERSANA News
Aug 28, 2025
Author(s): This episode of Pharma Pulse covers ACOG’s renewed support for COVID-19 vaccination during pregnancy, new real-world evidence confirming the safety of dapagliflozin and empagliflozin for type 2 diabetes, and a partnership between EVERSANA and Waltz Health to improve affordability and patient access. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering updates in maternal health guidance, real-world diabetes data, and a new partnership aimed at lowering drug costs and improving access. The American College of Obstetricians and Gynecologists (ACOG) has reaffirmed its support for COVID-19 vaccination during pregnancy, even as it distances itself from recent CDC guidance. ACOG emphasized that vaccination remains safe and effective for protecting both pregnant individuals and their newborns from severe illness. The statement underscores ongoing efforts to ensure maternal populations remain a focus in vaccine policy, especially as hesitancy persists in some communities. In other news, new real-world evidence shows that the SGLT2 inhibitors dapagliflozin and empagliflozin are safe and effective for patients with type 2 diabetes. The study found no new safety concerns, reinforcing their role in improving both glycemic control and cardiovascular outcomes. With diabetes prevalence continuing to rise globally, the findings strengthen confidence in SGLT2 therapies as a key option in managing long-term complications. Lastly, in market access news, EVERSANA and Waltz Health are joining forces to launch a platform designed to tackle drug costs and improve patient access. The system leverages data, analytics, and real-time pricing to help patients and providers identify the most affordable options at the point of care. By combining EVERSANA’s commercialization expertise with Waltz’s technology, the collaboration aims to improve transparency and reduce out-of-pocket burdens for patients navigating an increasingly complex drug pricing landscape. From maternal health guidance to real-world diabetes safety data and innovative pricing platforms, these stories highlight how science, practice, and technology are working together to improve patient care. That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com . Thanks for listening—until next time, stay well and stay informed. You can catch Pharma Pulse directly on Audioboom , Spotify , or iHeart . Newsletter Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
EVERSANA Frequently Asked Questions (FAQ)
When was EVERSANA founded?
EVERSANA was founded in 2018.
Where is EVERSANA's headquarters?
EVERSANA's headquarters is located at 190 North Milwaukee Street, Milwaukee.
What is EVERSANA's latest funding round?
EVERSANA's latest funding round is Other Investors.
Who are the investors of EVERSANA?
Investors of EVERSANA include JLL Partners, North Sky Capital and Revelation Partners.
Who are EVERSANA's competitors?
Competitors of EVERSANA include Amboss, Future Cardia, Medidata, Syneos Health, Parexel and 7 more.
Loading...
Compare EVERSANA to Competitors
TriApex is a contract research organization (CRO) focused on enabling drug research and development (R&D) for pharmaceutical enterprises and research institutions, with an emphasis on disease-oriented solutions. The company offers a range of services, including nonclinical research, clinical research, translational research, regulatory strategies, safety assessments, and laboratory services to support the drug development process. TriApex serves the pharmaceutical and research sectors, providing R&D services in ophthalmology, central nervous system (CNS) diseases, and metabolic diseases. TriApex was formerly known as Tripod Preclinical Research Laboratories. It was founded in 2008 and is based in Nanjing, China.
MedaSystems delivers a comprehensive platform for managing requests for investigational therapies. Its GxP‑compliant SaaS solution unifies Expanded Access, Post‑Trial Access, and Investigator‑Initiated Study workflows in a single workspace that seamlessly connects physicians with biopharma sponsors worldwide. MedaSystems automates inquiry intake, real‑time tracking, and regulatory‑ready data capture to remove administrative bottlenecks and foster collaboration between clinicians and life‑science teams. MedaSystems serves the enterprise, biotech, and contract research organization sectors within the life sciences domain. It was founded in 2021 and is based in Menlo Park, California.
PSL Group focuses on providing research and information solutions within the healthcare industry. The company offers market research services, including testing and tracking, to assist pharmaceutical and biotechnology companies with branding strategies and marketing initiatives. PSL Group also provides online fieldwork services for conducting Internet-based market research with various types of physicians. It was founded in 2015 and is based in New York, New York.
Care Access is a health research company that focuses on clinical research and the development of new medical treatments. The company offers services such as conducting clinical research studies, providing health screenings, and facilitating community engagement in health research. Care Access primarily serves the healthcare and clinical research sectors. It was founded in 2016 and is based in Boston, Massachusetts.
Axtria specializes in cloud software and data analytics in the life sciences industry. The company offers various products, such as life sciences products, including data management, advanced analytics, and omnichannel customer engagement. It primarily serves the life sciences sector, including pharmaceuticals, biotechnology, and medical devices. The company was founded in 2009 and is based in Berkeley Heights, New Jersey.
Trinity Life Sciences provides advisory and analytics services within the life sciences industry. The company offers services including brand planning, competitive intelligence, corporate strategy, and market access, along with analytics solutions such as commercial analytics and real-world evidence. Trinity Life Sciences serves the life sciences sector, providing solutions to support drug development and market strategies. It was founded in 1996 and is based in Waltham, Massachusetts.
Loading...